Cubist to Present at February Investor Conferences

  Cubist to Present at February Investor Conferences

Leerink Swann Global Healthcare Conference 2013 2013 RBC Capital Markets'
Global Healthcare Conference

Business Wire

LEXINGTON, Mass. -- January 29, 2013

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company
management will present at investor conferences during February to discuss the
company’s business activities, financial outlook, and current news.

  *Mike Bonney, CEO, will present on Thursday, February 14^th, 2013 at 4:05
    p.m. Eastern Time, at the Leerink Swann Global Healthcare Conference being
    held at the Waldorf Astoria Hotel in New York City.
  *David McGirr, SVP & CFO, will present on Tuesday, February 26^th, 2013 at
    3:05 p.m. Eastern Time, at the 2013 RBC Capital Markets’ Global Healthcare
    Conference being held at the New York Palace Hotel in New York City.

These presentations will be accessible live through Cubist’s website at
www.cubist.com in the Investor Relations Conference Calendar section and will
remain available there for a period of 30 days after the presentations.

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
research, development, and commercialization of pharmaceutical products that
address significant unmet medical needs in the acute care environment. Cubist
is headquartered in Lexington, Mass. Additional information can be found at
Cubist’s website.

Contact:

INVESTORS:
Cubist Pharmaceuticals, Inc.
Eileen C. McIntyre, 781-860-8533
Senior Director, Investor Relations
eileen.mcintyre@cubist.com
or
MEDIA:
Cubist Pharmaceuticals, Inc.
Julie DiCarlo, 781-860-8063
Senior Director, Corporate Communications
julie.dicarlo@cubist.com
 
Press spacebar to pause and continue. Press esc to stop.